Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2026-04-27 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
关于会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (信永中和会计师事务所) in conducting the audit for the company's 2025 annual audit. It discusses the auditor's qualifications, audit procedures, and the company's assessment of the auditor's performance. It does not contain the actual audit report or financial statements but rather an evaluation of the auditor's work and compliance with regulations. The document length is short (1395 characters), and it is a standalone report about the audit firm's performance, not the full annual report or audit report itself. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information excluding full annual reports. FY 2025
2026-04-27 Chinese
关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction involving the company and its related entities. It details the transaction overview, decision and approval process by the board, related parties' information, pricing policy, and the impact of the transaction on the company. There is no financial statement or report data included, nor is it a report publication announcement. The content fits the category of a regulatory announcement about a related party transaction, which is typically classified under Regulatory Filings (RNS) as it does not fit other more specific categories like Annual Report, Interim Report, or Capital Update. The document length is short (2124 characters), and it is a formal announcement of a corporate event rather than a financial report or presentation.
2026-04-27 Chinese
关于召开2025年年度股东会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2025 Annual General Meeting (AGM) of the company, including details about the meeting date, voting methods, agenda items, and proxy forms. It does not contain the actual annual report or financial statements but rather informs shareholders about the upcoming meeting and the matters to be discussed and voted on. The document length is 3654 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-27 Chinese
董事会关于独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of the company's independent directors. It references compliance with regulatory rules about independent directors and confirms their independence status. The content is focused on governance and board-related information rather than financial results, audit, or shareholder voting. It is not an announcement of a report publication but a substantive governance report. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters.
2026-04-27 Chinese
关于确认2025年度关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the confirmation of related party transactions for the fiscal year 2025. It details the nature, amounts, and parties involved in these related transactions, the decision-making and approval process by the board and committees, and the impact of these transactions on the company. The document is not a full financial report, audit report, or earnings release, but rather a regulatory announcement about related party transactions. It does not contain financial statements or detailed financial analysis but focuses on disclosure of related party dealings and their approval. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-27 Chinese
2025年度独立董事述职报告（孙继伟）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 by an independent director of the company. It details the director's duties, attendance at meetings, participation in committees, communication with shareholders, and overall evaluation of the company's governance and compliance during the year. It references compliance with laws and regulations, internal controls, and the director's independent judgment. The document is a detailed report on the independent director's activities and responsibilities over the year, which fits the category of Board/Management Information (MANG) as it relates to governance and management oversight rather than a full annual report or financial statement. It is not an announcement of voting results, not a financial report, nor a proxy or remuneration statement. Therefore, the best classification is MANG with high confidence.
2026-04-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.